<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">epilepsia</journal-id><journal-title-group><journal-title xml:lang="en">Epilepsy and paroxysmal conditions</journal-title><trans-title-group xml:lang="ru"><trans-title>Эпилепсия и пароксизмальные состояния</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2077-8333</issn><issn pub-type="epub">2311-4088</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17749/2077-8333/epi.par.con.2024.201</article-id><article-id custom-type="elpub" pub-id-type="custom">epilepsia-1144</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL CASES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ СЛУЧАИ</subject></subj-group></article-categories><title-group><article-title>Increased postictal creatine kinase in epilepsy patients</article-title><trans-title-group xml:lang="ru"><trans-title>Постиктальное повышение креатинкиназы у больных эпилепсией</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9988-3525</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Липатова</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lipatova</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Липатова Людмила Валентиновна - д.м.н., проф.</p><p>Кондратьевский пр., д. 72 лит. А, Санкт-Петербург, 195271</p><p>WoS ResearcherID M-5928-2018, Scopus Author ID 36892509600</p></bio><bio xml:lang="en"><p>Liudmila V. Lipatova - Dr. Sci. Med., Prof.</p><p>72 lit. А Kondratievsky Ave., Saint Petersburg, 195271</p><p>WoS ResearcherID M-5928-2018, Scopus Author ID 36892509600</p></bio><email xlink:type="simple">l_lipatova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8947-1463</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Саковский</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sakovsky</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Саковский Игорь Всеволодович - к.м.н., доцент.</p><p>Кондратьевский пр., д. 72 лит. А, Санкт-Петербург, 195271</p></bio><bio xml:lang="en"><p>Igor V. Sakovsky - PhD, Assoc. Prof.</p><p>72 lit. А Kondratievsky Ave., Saint Petersburg, 195271</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Частное образовательное учреждение высшего образования «Санкт-Петербургский медико-социальный институт»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Saint-Peterburg Medical and Social Institute</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>17</day><month>01</month><year>2025</year></pub-date><volume>16</volume><issue>4</issue><fpage>333</fpage><lpage>337</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Lipatova L.V., Sakovsky I.V., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Липатова Л.В., Саковский И.В.</copyright-holder><copyright-holder xml:lang="en">Lipatova L.V., Sakovsky I.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.epilepsia.su/jour/article/view/1144">https://www.epilepsia.su/jour/article/view/1144</self-uri><abstract><p>Excessive muscle activity during generalized convulsive seizures in epilepsy patients in some cases can cause significant changes in blood plasma biochemical parameters, increased level of a set of metabolites, particularly, serum creatine kinase, accompanied by azotemia, which leads to prominent diagnostic and therapeutic difficulties. It is necessary to monitor the creatine kinase concentration after seizures, especially in case of electrolyte disturbances. To correct elevated creatine kinase or myoglobin levels, infusion therapy, urine alkalinization along with diuretics administration should be performed.</p></abstract><trans-abstract xml:lang="ru"><p>Избыточная мышечная активность при генерализованных судорожных приступах у больных эпилепсией в ряде случаев может приводить к существенным изменениям биохимических показателей плазмы крови, повышению уровня ряда метаболитов, в частности сывороточной креатинкиназы, сопровождаться азотемией, что вызывает значительные диагностические и терапевтические трудности. Необходимо осуществлять мониторинг концентрации креатинкиназы после судорог, особенно при наличии у пациента электролитных нарушений. Для коррекции повышенного уровня креатинкиназы или миоглобина следует проводить инфузионную терапию, ощелачивание мочи, вводить диуретики.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Эпилепсия</kwd><kwd>судорожные приступы</kwd><kwd>креатинкиназа</kwd><kwd>острое повреждение почек</kwd><kwd>ОПП</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Epilepsy</kwd><kwd>seizures</kwd><kwd>creatine kinase</kwd><kwd>acute kidney injury</kwd><kwd>AKI</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">McMahon G.M., Zeng X., Waikar S.S. A risk prediction score for kidney failure or mortality in rhabdomyolysis. JAMA Intern Med. 2013; 173 (19): 1821–8. https://doi.org/10.1001/jamainternmed.2013.9774.</mixed-citation><mixed-citation xml:lang="en">McMahon G.M., Zeng X., Waikar S.S. A risk prediction score for kidney failure or mortality in rhabdomyolysis. JAMA Intern Med. 2013; 173 (19): 1821–8. https://doi.org/10.1001/jamainternmed.2013.9774.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Zimmerman J.L., Shen M.C. Rhabdomyolysis. Chest. 2013; 144 (3): 1058–65. https://doi.org/10.1378/chest.12-2016.</mixed-citation><mixed-citation xml:lang="en">Zimmerman J.L., Shen M.C. Rhabdomyolysis. Chest. 2013; 144 (3): 1058–65. https://doi.org/10.1378/chest.12-2016.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bosch X., Poch E., Grau J.M. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009; 361 (1): 62–72. https://doi.org/10.1056/NEJMra0801327.</mixed-citation><mixed-citation xml:lang="en">Bosch X., Poch E., Grau J.M. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009; 361 (1): 62–72. https://doi.org/10.1056/NEJMra0801327.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Alpers J.P., Jones L.K. Jr. Natural history of exertional rhabdomyolysis: a population-based analysis. Muscle Nerve. 2010; 42 (4): 487–91. https://doi.org/10.1002/mus.21740.</mixed-citation><mixed-citation xml:lang="en">Alpers J.P., Jones L.K. Jr. Natural history of exertional rhabdomyolysis: a population-based analysis. Muscle Nerve. 2010; 42 (4): 487–91. https://doi.org/10.1002/mus.21740.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Tong K., Yu G.S. Acute recurrent rhabdomyolysis in a Chinese boy associated with a novel compound heterozygous LPIN1 variant: a case report. BMC Neurol. 2021; 21 (1): 42. https://doi.org/10.1186/s12883-021-02050-w.</mixed-citation><mixed-citation xml:lang="en">Tong K., Yu G.S. Acute recurrent rhabdomyolysis in a Chinese boy associated with a novel compound heterozygous LPIN1 variant: a case report. BMC Neurol. 2021; 21 (1): 42. https://doi.org/10.1186/s12883-021-02050-w.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Backer H.C., Busko M., Krause F.G., et al. Exertional rhabdomyolysis and causes of elevation of creatine kinase. Phys Sportsmed. 2020; 48 (2): 179–85. https://doi.org/10.1080/00913847.2019.1669410.</mixed-citation><mixed-citation xml:lang="en">Backer H.C., Busko M., Krause F.G., et al. Exertional rhabdomyolysis and causes of elevation of creatine kinase. Phys Sportsmed. 2020; 48 (2): 179–85. https://doi.org/10.1080/00913847.2019.1669410.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Nass R.D., Meiling S., Andrié R.P., et al. Laboratory markers of cardiac and metabolic complications after generalized tonic-clonic seizures. BMC Neurol. 2017; 17: 187. https://doi.org/10.1186/s12883-017-0965-4.</mixed-citation><mixed-citation xml:lang="en">Nass R.D., Meiling S., Andrié R.P., et al. Laboratory markers of cardiac and metabolic complications after generalized tonic-clonic seizures. BMC Neurol. 2017; 17: 187. https://doi.org/10.1186/s12883-017-0965-4.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Petejova N., Martinek A. Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review. Crit Care. 2014; 18 (3): 224. https://doi.org/10.1186/cc13897.</mixed-citation><mixed-citation xml:lang="en">Petejova N., Martinek A. Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review. Crit Care. 2014; 18 (3): 224. https://doi.org/10.1186/cc13897.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lee I.H., Ahn D.J. Rhabdomyolysis and acute kidney injury associated with salmonella infection: a report of 2 cases. Am J Case Rep. 2022; 23: e936407. https://doi.org/10.12659/AJCR.936407.</mixed-citation><mixed-citation xml:lang="en">Lee I.H., Ahn D.J. Rhabdomyolysis and acute kidney injury associated with salmonella infection: a report of 2 cases. Am J Case Rep. 2022; 23: e936407. https://doi.org/10.12659/AJCR.936407.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Horwitz H., Woeien V.A., Petersen L.W., Jimenez-Solem E. Hypokalemia and rhabdomyolysis. J Pharmacol Pharmacother. 2015; 6 (2): 98–9. https://doi.org/10.4103/0976-500X.155488.</mixed-citation><mixed-citation xml:lang="en">Horwitz H., Woeien V.A., Petersen L.W., Jimenez-Solem E. Hypokalemia and rhabdomyolysis. J Pharmacol Pharmacother. 2015; 6 (2): 98–9. https://doi.org/10.4103/0976-500X.155488.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Grifoni E., Fabbri A., Ciuti G., et al. Hypokalemia-induced rhabdomyolysis. Intern Emerg Med. 2014; 9 (4): 487–8. https://doi.org/10.1007/s11739-013-1033-8.</mixed-citation><mixed-citation xml:lang="en">Grifoni E., Fabbri A., Ciuti G., et al. Hypokalemia-induced rhabdomyolysis. Intern Emerg Med. 2014; 9 (4): 487–8. https://doi.org/10.1007/s11739-013-1033-8.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Jung Y.L., Kang J.Y. Rhabdomyolysis following severe hypokalemia caused by familial hypokalemic periodic paralysis. World J Clin Cases. 2017; 5 (2): 56–60. https://doi.org/10.12998/wjcc.v5.i2.56.</mixed-citation><mixed-citation xml:lang="en">Jung Y.L., Kang J.Y. Rhabdomyolysis following severe hypokalemia caused by familial hypokalemic periodic paralysis. World J Clin Cases. 2017; 5 (2): 56–60. https://doi.org/10.12998/wjcc.v5.i2.56.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Khow K.S., Lau S.Y., Li J.Y., Yong T.Y. Asymptomatic elevation of creatine kinase in patients with hyponatremia. Ren Fail. 2014; 36 (6): 908–11. https://doi.org/10.3109/0886022X.2014.900600.</mixed-citation><mixed-citation xml:lang="en">Khow K.S., Lau S.Y., Li J.Y., Yong T.Y. Asymptomatic elevation of creatine kinase in patients with hyponatremia. Ren Fail. 2014; 36 (6): 908–11. https://doi.org/10.3109/0886022X.2014.900600.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Chavez L.O., Leon M., Einav S., Varon J. Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice. Crit Care. 2016; 20 (1): 135. https://doi.org/10.1186/s13054-016-1314-5.</mixed-citation><mixed-citation xml:lang="en">Chavez L.O., Leon M., Einav S., Varon J. Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice. Crit Care. 2016; 20 (1): 135. https://doi.org/10.1186/s13054-016-1314-5.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Levey A.S., James M.T. Acute Kidney Injury. Ann Intern Med. 2017; 167 (9): ITC66–80. https://doi.org/10.7326/AITC201711070.</mixed-citation><mixed-citation xml:lang="en">Levey A.S., James M.T. Acute Kidney Injury. Ann Intern Med. 2017; 167 (9): ITC66–80. https://doi.org/10.7326/AITC201711070.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Barras P., Siclari F., Hugli O., et al. A potential role of hypophosphatemia for diagnosing convulsive seizures: a case-control study. Epilepsia. 2019; 60 (8): 1580–5. https://doi.org/10.1111/epi.16090.</mixed-citation><mixed-citation xml:lang="en">Barras P., Siclari F., Hugli O., et al. A potential role of hypophosphatemia for diagnosing convulsive seizures: a case-control study. Epilepsia. 2019; 60 (8): 1580–5. https://doi.org/10.1111/epi.16090.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Wang K., Yang J., Xu W., et al. Characteristics and treatments of patients with significantly elevated creatine kinase levels induced by seizures: case report and literature review. Clin Case Rep. 2023; 11 (8): e7788. https://doi.org/10.1002/ccr3.7788.</mixed-citation><mixed-citation xml:lang="en">Wang K., Yang J., Xu W., et al. Characteristics and treatments of patients with significantly elevated creatine kinase levels induced by seizures: case report and literature review. Clin Case Rep. 2023; 11 (8): e7788. https://doi.org/10.1002/ccr3.7788.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Agus Z.S. Mechanisms and causes of hypomagnesemia. Curr Opin Nephrol Hypertens. 2016; 25 (4): 301–7. https://doi.org/10.1097/MNH.0000000000000238.</mixed-citation><mixed-citation xml:lang="en">Agus Z.S. Mechanisms and causes of hypomagnesemia. Curr Opin Nephrol Hypertens. 2016; 25 (4): 301–7. https://doi.org/10.1097/MNH.0000000000000238.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Bragadottir G., Redfors B., Ricksten S.E. Mannitol increases renal blood flow and maintains filtration fraction and oxygenation in postoperative acute kidney injury: a prospective interventional study. Crit Care. 2012; 16 (4): R159. https://doi.org/10.1186/cc11480.</mixed-citation><mixed-citation xml:lang="en">Bragadottir G., Redfors B., Ricksten S.E. Mannitol increases renal blood flow and maintains filtration fraction and oxygenation in postoperative acute kidney injury: a prospective interventional study. Crit Care. 2012; 16 (4): R159. https://doi.org/10.1186/cc11480.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Brigo F., Igwe S.C., Erro R., et al. Postictal serum creatine kinase for the differential diagnosis of epileptic seizures and psychogenic non-epileptic seizures: a systematic review. J Neurol. 2015; 262 (2): 251–7. https://doi.org/10.1007/s00415-014-7369-9.</mixed-citation><mixed-citation xml:lang="en">Brigo F., Igwe S.C., Erro R., et al. Postictal serum creatine kinase for the differential diagnosis of epileptic seizures and psychogenic non-epileptic seizures: a systematic review. J Neurol. 2015; 262 (2): 251–7. https://doi.org/10.1007/s00415-014-7369-9.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Neufeld M.Y., Treves T.A., Chistik V., Korczyn A.D. Sequential serum creatine kinase determination differentiates vasovagal syncope from generalized tonic-clonic seizures. Acta Neurol Scand. 1997; 95 (3): 137–9. https://doi.org/10.1111/j.1600-0404.1997.tb00084.x.</mixed-citation><mixed-citation xml:lang="en">Neufeld M.Y., Treves T.A., Chistik V., Korczyn A.D. Sequential serum creatine kinase determination differentiates vasovagal syncope from generalized tonic-clonic seizures. Acta Neurol Scand. 1997; 95 (3): 137–9. https://doi.org/10.1111/j.1600-0404.1997.tb00084.x.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Bauer J. Epilepsy and prolactin in adults: a clinical review. Epilepsy Res. 1996; 24 (1): 1–7. https://doi.org/10.1016/0920-1211(96)00009-5.</mixed-citation><mixed-citation xml:lang="en">Bauer J. Epilepsy and prolactin in adults: a clinical review. Epilepsy Res. 1996; 24 (1): 1–7. https://doi.org/10.1016/0920-1211(96)00009-5.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Dobson H., Al Maawali S., Malpas C., et al. Elevated plasma neurofilament light and glial fibrillary acidic protein in epilepsy versus nonepileptic seizures and nonepileptic disorders. Epilepsia. 2024. https://doi.org/10.1111/epi.18065.</mixed-citation><mixed-citation xml:lang="en">Dobson H., Al Maawali S., Malpas C., et al. Elevated plasma neurofilament light and glial fibrillary acidic protein in epilepsy versus nonepileptic seizures and nonepileptic disorders. Epilepsia. 2024. https://doi.org/10.1111/epi.18065.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
